Cytokines and atherosclerosis: a comprehensive review of studies in mice

@article{Kleemann2008CytokinesAA,
  title={Cytokines and atherosclerosis: a comprehensive review of studies in mice},
  author={R. Kleemann and S. Zadelaar and T. Kooistra},
  journal={Cardiovascular Research},
  year={2008},
  volume={79},
  pages={360 - 376}
}
In the past few years, inflammation has emerged as a major driving force of atherosclerotic lesion development. It is now well-established that from early lesion to vulnerable plaque formation, numerous cellular and molecular inflammatory components participate in the disease process. The most prominent cells that invade in evolving lesions are monocyte-derived macrophages and T-lymphocytes. Both cell types produce a wide array of soluble inflammatory mediators (cytokines, chemokines) which are… Expand
Cytokines and Immune Responses in Murine Atherosclerosis.
IL-9 aggravates the development of atherosclerosis in ApoE-/- mice.
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 103 REFERENCES
Protective role of interleukin-10 in atherosclerosis.
Interleukin-10 blocks atherosclerotic events in vitro and in vivo.
Role of pro- and anti-inflammatory cytokines during inflammation: experimental and clinical findings.
  • C. Dinarello
  • Medicine
  • Journal of biological regulators and homeostatic agents
  • 1997
IL-20 Is Expressed in Atherosclerosis Plaques and Promotes Atherosclerosis in Apolipoprotein E–Deficient Mice
Interleukins in Atherosclerosis: Molecular Pathways and Therapeutic Potential
Interleukin-6 exacerbates early atherosclerosis in mice.
IL-6 and the acute phase response in murine atherosclerosis.
The role of interleukin-4 and interleukin-12 in the progression of atherosclerosis in apolipoprotein E-deficient mice.
...
1
2
3
4
5
...